Medications

New monoclonal antibody shows promise for severe asthma

A new monoclonal antibody therapy shows promise in offering an alternative treatment for patients suffering from moderate-to-severe asthma. Research led by Michael E. Wechsler, MD, MMSc, director of the National Jewish Health ...

Inflammatory disorders

Severe asthma: Gallopamil confirmed as a therapeutic approach

A team of Inserm researchers from the Cardio-Thoracic Research Centre of Bordeaux (Inserm/University of Bordeaux and Bordeaux University Hospital) has demonstrated the clinical efficacy of gallopamil in 31 patients with severe ...

Gastroenterology

Q&A: Irritable bowel syndrome and lifestyle changes

DEAR MAYO CLINIC: I was diagnosed with irritable bowel syndrome and my primary care doctor recommended that I manage the condition without medication. Is that typical or will I also need medication to control my symptoms?

page 3 from 15